The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 737.00
Bid: 738.00
Ask: 743.00
Change: -12.00 (-1.60%)
Spread: 5.00 (0.678%)
Open: 718.00
High: 750.00
Low: 718.00
Prev. Close: 749.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM

27 Jun 2014 11:15

RNS Number : 7519K
Acal PLC
27 June 2014
 



 

 

27 JUNE 2014

 

 

Acal plc

("Acal" or the "Group")

 

Notice of Annual General Meeting 2014

 

 

Acal plc (LSE: ACL), the European specialist provider of advanced technology solutions, has today issued to its shareholders the Notice of Annual General Meeting ("AGM") and shareholder proxy form. The AGM will be held at Acal's head office at 2 Chancellor Court, Occam Road, Surrey Research Park, Guildford, Surrey GU2 7AH on 29 July 2014 at 11.00 a.m..

 

Copies of the Notice of AGM and the proxy form will be available on Acal's website (www.acalplc.co.uk).

 

Acal will also submit a copy of the Notice of AGM and shareholder proxy form to the National Storage Mechanism and they will shortly be available for inspection at www.morningstar.co.uk/uk/NSM.

 

The Group published its Annual Report and Accounts for the Group for the year ended 31 March 2014 on 5 June 2014. Copies of the Annual Report and Accounts have been posted to shareholders today, along with the Notice of AGM and shareholder proxy form. The Annual Report and Accounts is also available to be downloaded from Acal's website and is available for inspection at www.morningstar.co.uk/uk/NSM.

 

For further information:

 

Acal plc

Gary Shillinglaw - Group Company Secretary 01483 544500

 

Instinctif Partners 0207 457 2020

Mark Garraway

Helen Tarbet

 

 

Notes to Editors:

 

Acal is a European leader in specialist electronics, designing, manufacturing and distributing specialist electronic, photonic and medical products for the industrial and healthcare sectors. It is the only such provider with an infrastructure to deliver a broad range of specialist products and bespoke solutions across Europe. The Electronics division has completed seven acquisitions in the last four years, more than trebling its specialist revenues. Acal's strategy is to further enhance its leadership position through organic growth, complementary acquisitions and continued enhancement of its custom service capabilities. The division has operating companies across Europe including the UK, Germany, France, Benelux, Italy, Poland, Spain and the Nordic region as well as in Asia (China and South Korea) and Africa (South Africa). Businesses comprise AcalBFi, Hectronic, MTC, Myrra Group, RSG, Stortech and Vertec.

 

Disclaimer:

 

This announcement has been prepared in accordance with English law, the Listing Rules and the Disclosure and Transparency Rules and information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside England. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOAUBARRSSANUAR
Date   Source Headline
18th Apr 20247:00 amRNSFull Year Trading Update
28th Mar 20247:30 amRNSDirector Declaration
22nd Mar 20248:09 amRNSNotification of Major Holdings
20th Mar 20243:45 pmRNSDirector/PDMR Shareholding
14th Mar 20241:21 pmRNSDirector/PDMR Shareholding
19th Feb 20244:07 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSTrading Update
29th Jan 202410:31 amRNSDirector / PDMR Shareholding
8th Jan 20248:41 amRNSNotification of Major Holdings
4th Jan 20244:03 pmRNSNotification of Major Holdings
21st Dec 20233:57 pmRNSNotification of Major Holdings
13th Dec 20239:03 amRNSNotification of Major Holdings
8th Dec 202310:52 amRNSNotification of Major Holdings
5th Dec 20237:00 amRNSInterim Results
22nd Nov 20238:30 amRNSNotice of Interim Results
11th Oct 20237:00 amRNSFirst Half Trading Update
15th Sep 20239:11 amRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSAcquisition of 2J Antennas Group
5th Sep 20232:17 pmRNSNotification of Major Holdings
31st Aug 20237:00 amRNSAcquisition completion - Silvertel
1st Aug 20237:00 amRNSAcquisition of Silvertel
24th Jul 20232:31 pmRNSResults of Annual General Meeting
24th Jul 20237:00 amRNSTrading Update
27th Jun 202310:53 amRNSDirector / PDMR Shareholding
27th Jun 202310:47 amRNSNotification of Major Holdings
22nd Jun 202312:35 pmRNSAnnual Report & Notice of AGM
19th Jun 20238:35 amRNSNotification of Major Holdings
15th Jun 20239:51 amRNSDirector LTIP Award
7th Jun 20237:00 amRNSPreliminary results
1st Jun 20232:50 pmRNSNotification of Major Holdings
30th May 20237:00 amRNSAppointment of Non-Executive Director
18th May 20231:33 pmRNSNotification of Major Holdings
17th May 202310:25 amRNSNotice of Full Year Results
19th Apr 20237:00 amRNSFull Year Trading Update
18th Apr 20237:00 amRNSNotification of Major Holdings
29th Mar 20235:47 pmRNSNotification of Major Holdings
15th Mar 20233:53 pmRNSNotification of Major Holdings
15th Mar 20238:37 amRNSNotification of Major Holdings
15th Mar 20237:00 amRNSNotification of Major Holdings
23rd Feb 20232:58 pmRNSNotification of Major Holdings
20th Feb 20239:48 amRNSNotification of Major Holdings
15th Feb 20235:33 pmRNSNotification of Major Holdings
13th Feb 202311:36 amRNSNotification of Major Holdings
25th Jan 20237:00 amRNSQ3 Trading Update and Acquisition Completion
6th Jan 20231:41 pmRNSNotification of Major Holdings
6th Jan 20238:24 amRNSNotification of Major Holdings
3rd Jan 202310:38 amRNSNotification of Major Holdings
22nd Dec 20227:00 amRNSAcquisition of Magnasphere Corporation
14th Dec 20224:31 pmEQSParadigm Biopharmaceuticals (PAR): Adapted therapies to meet unmet demand
5th Dec 20229:53 amEQSdiscoverIE Group (DSCV): Focused on sustainable growth

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.